JPMorgan Downgrades Braskem S.A. (BAK) to Neutral

JPMorgan analyst Milene Clifford Carvalho downgraded Braskem S.A. (NYSE: BAK) from Overweight to Neutral with a price target of $11.00 (from $11.50).

For an analyst ratings summary and ratings history on Braskem S.A. click here. For more ratings news on Braskem S.A. click here.

Shares of Braskem S.A. closed at $11.53 yesterday.

You May Also Be Interested In

• Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
• Nutanix (NTNX) PT Raised to $80 at Oppenheimer Into EPS
• Marti Technologies (MRT) PT Raised to $6 at Benchmark on Stronger Growth, Improved Earnings Visibility